Sequencing of agents for metastatic renal cell carcinoma: Can we customize therapy? Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Molecular Targeted Therapy

abstract

  • Currently, the sequence of therapy is based on patient and physician decision, which may be influenced by comorbidities and toxicity profiles.

publication date

  • February 2012

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2011.10.032

PubMed ID

  • 22055147

Additional Document Info

start page

  • 307

end page

  • 16

volume

  • 61

number

  • 2